Respiratory Medicine
Volume 104, Issue 8 , Pages 1189-1196, August 2010

Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions

  • Carlos A. Vaz Fragoso

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
    • Corresponding Author InformationCorresponding author. Internal Medicine, Clinical Epidemiology Research Center, VA Connecticut Healthcare System, Mailcode 151B, West Haven, CT 06516, USA. Tel.: +1 203 688 9423; fax: +1 203 688 4209.
  • ,
  • John Concato

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
  • ,
  • Gail McAvay

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
  • ,
  • Peter H. Van Ness

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
  • ,
  • Carolyn L. Rochester

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
  • ,
  • H. Klar Yaggi

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
  • ,
  • Thomas M. Gill

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA

Received 18 August 2009; accepted 20 October 2009. published online 04 March 2010.

Summary 

Background

Among older persons, we previously endorsed a two-step spirometric definition of chronic obstructive pulmonary disease (COPD) that requires a ratio of forced expiratory volume in 1sec to forced vital capacity (FEV1/FVC) below .70, and an FEV1 below the 5th or 10th standardized residual percentile (“SR-tile strategy”).

Objective

To evaluate the clinical validity of an SR-tile strategy, compared to a current definition of COPD, as published by the Global Initiative for Obstructive Lung Disease (GOLD-COPD), in older persons.

Methods

We assessed national data from 2480 persons aged 65–80 years. In separate analyses, we evaluated the association of an SR-tile strategy with mortality and respiratory symptoms, relative to GOLD-COPD. As per convention, GOLD-COPD was defined solely by an FEV1/FVC<.70, with severity staged according to FEV1 cut-points at 80 and 50 percent predicted (%Pred).

Results

Among 831 participants with GOLD-COPD, the risk of death was elevated only in 179 (21.5%) of those who also had an FEV1<5th SR-tile; and the odds of having respiratory symptoms were elevated only in 310 (37.4%) of those who also had an FEV1<10th SR-tile. In contrast, GOLD-COPD staged at an FEV1 50–79%Pred led to misclassification (overestimation) in terms of 209 (66.4%) and 77 (24.6%) participants, respectively, not having an increased risk of death or likelihood of respiratory symptoms.

Conclusion

Relative to an SR-tile strategy, the majority of older persons with GOLD-COPD had neither an increased risk of death nor an increased likelihood of respiratory symptoms. These results raise concerns about the clinical validity of GOLD guidelines in older persons.

Keywords: COPD, Spirometry, Respiratory symptoms, Mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(10)00048-X

doi:10.1016/j.rmed.2009.10.030

Respiratory Medicine
Volume 104, Issue 8 , Pages 1189-1196, August 2010